| Trial Identifier: | D7960C00008 |
| Sponsor: | AstraZeneca |
| Start Date: | December 2024 |
| Primary Completion Date: | June 2027 |
| Study Completion Date: | June 2027 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| CN | Baotou, CN, 14010 |
| CN | Beijing, CN, 100029 |
| CN | Chengdu, CN, 610000 |
| CN | Chongqing, CN, 402260 |
| CN | Deyang, CN, 618000 |
| CN | Nanchong, CN, 637900 |
| CN | Shanghai, CN, 200032 |
| CN | Tianjin, CN, 300457 |
| CN | Wuhan, CN, 430030 |
| CN | Wuhan, CN, 430010 |
| CN | Wuhan, CN, 430060 |
| CN | Xi'an, CN, 710068 |
| CN | Xianyang, CN, 750004 |
| CN | Yinchuan, CN, 750004 |
| CN | Zigong, CN, 643021 |
| HK | Hong Kong, HK |
| HK | Hong Kong, HK, 999077 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company